Rhode Island 2025 Regular Session

Rhode Island Senate Bill S0268

Introduced
2/13/25  
Refer
2/13/25  
Report Pass
6/10/25  

Caption

Requires every individual or group health insurance contract effective on or after January 1, 2026, to provide coverage to the insured and the insured's spouse and dependents for all FDA-approved contraceptive drugs, devices and other products.

Impact

The bill's impact on state laws includes expanding insurance mandates for contraceptive coverage, thereby potentially increasing enrollment in plans that include such services and improving public health outcomes related to reproductive health. It seeks to eliminate cost barriers that have traditionally hindered access to contraceptive services by requiring plans to provide them without deductibles or other forms of cost-sharing. This move has the potential to lead to increased contraceptive usage, further promoting family planning and informed healthcare choices among insured individuals.

Summary

S0268 is a proposed act that aims to amend insurance regulations in relation to contraceptive methods and services. Specifically, the bill requires that every individual or group health insurance contract effective on or after January 1, 2026, is mandated to provide coverage for all FDA-approved contraceptive drugs and devices, voluntary sterilization procedures, alongside counseling and follow-up services. This legislation is designed to ensure that individuals and their spouses and dependents have access to comprehensive contraceptive care without copayments or additional charges, aiming to increase accessibility and affordability of reproductive healthcare.

Sentiment

The sentiment surrounding S0268 varies significantly among stakeholders. Proponents, including various health advocacy groups, view it positively, emphasizing the importance of accessible contraceptive coverage as a critical component of healthcare. They argue that the bill is a step forward in ensuring health equity. Conversely, opponents, particularly from certain religious groups, express concerns regarding mandates that may conflict with their beliefs regarding contraception, fearing that such regulations could undermine their ability to make choices aligned with their values.

Contention

Notable points of contention revolve around the inclusion of voluntary sterilization in the required coverage and the implications for religious employers who may wish to exclude contraceptive services based on their doctrinal beliefs. The bill allows for some exemptions, but the conditions under which these apply are a source of debate, as opponents argue that the legislation could lead to unintended consequences and a decrease in religious freedoms regarding healthcare decisions.

Companion Bills

No companion bills found.

Similar Bills

RI H6047

Mandates all health insurance contracts from January 1, 2026, to cover FDA-approved contraceptives, sterilization, contraception counseling, follow-up services, and a twelve-month supply for Medicaid recipients.

RI S0562

Accident And Sickness Insurance Policies

RI H7255

Requires every individual or group health insurance contract effective on or after January 1, 2025, to provide coverage to the insured and the insured's spouse and dependents for all FDA-approved contraceptive drugs, devices and other products.

RI S2088

Requires every individual or group health insurance contract effective on or after January 1, 2025, to provide coverage to the insured and the insured's spouse and dependents for all FDA-approved contraceptive drugs, devices and other products.

RI H5477

Accident And Sickness Insurance Policies

MS SB2552

Contraceptive Equity Act of 2024; enact.

MN HF1485

Coverage of over-the=counter contraceptive drugs, devices, and products by insurers and medical assistance required; and reports required.

MN SF1752

Coverage of over-the-counter contraceptive, drugs, devices, and products requirement by insurers and medical assistance